Jubilant Life Sciences Limited - Evaluate Options To Create Focused Entities For JLL Businesses

The board of directors of the Company (Board) at its meeting held on July 26, 2019 considered the option of reorganizing its businesses with the following objectives:

(a) create separate and focused entities for Pharmaceuticals and Life Science Ingredients businesses to manage different risks, rewards and regulatory requirements;

(b) enable strategic growth for these businesses with optimal capital structure;

(c) potentially unlock shareholder value with direct ownership in each of the business entities.

The Board has constituted a Committee to evaluate various options including reorganisation / demerger of business undertakings on a going concern basis and provide its recommendations. Any decision in this regard will be after due evaluation and consideration by the Board and be subject to all necessary consents and approvals.

The Company will at the relevant time take necessary steps to comply with all applicable laws and regulations including the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is for information and record.

Pdf Link: Jubilant Life Sciences Limited - Evaluate Options To Create Focused Entities For JLL Businesses

Source : BSE - www.bseindia.com